Outcomes in ADAPT or Solitaire group
| Outcomesa | Solitaire Group (n = 119) | ADAPT Group (n= 124) | Relative Risk | P Value | Relative Riskb | P Valueb |
|---|---|---|---|---|---|---|
| Successful revascularization at final angiogram | 82 (68.9) | 102 (82.3) | 1.19 (1.03–1.38) | .015 | 1.18 (1.02–1.37) | .022 |
| Early neurologic improvement | 61 (55.5) | 56 (57.1) | 1.03 (0.81–1.31) | .81 | 1.00 (0.78–1.28) | .99 |
| 90-day excellent outcome | 44 (38.3) | 45 (39.1) | 1.02 (0.73–1.42) | .89 | 1.10 (0.78–1.56) | .58 |
| 90-day favorable outcome | 63 (54.8) | 61 (53.0) | 0.97 (0.76–1.23) | .79 | 1.05 (0.82–1.35) | .70 |
| 90-day mortality | 20 (17.4) | 26 (22.6) | 1.30 (0.77–2.19) | .32 | 1.14 (0.64–2.01) | .65 |
| ENT | 8 (6.8) | 7 (5.7) | – | .70 | – | – |
| sICH | 7 (5.9) | 3 (2.4) | – | .21 | – | – |
Note:—ENT indicates embolization in a new territory rate; sICH, symptomatic intracranial hemorrhage.
↵a Early neurologic improvement is defined as an NIHSS score 0–1 at 24 hours or a decrease of ≥4 points in NIHSS scores at 24 hours. Excellent outcome is defined as an mRS score of ≤1; favorable outcome, an mRS score of ≤2; and successful recanalization, an mTICI score of 2b–3 at final angiography.
↵b Adjusted for between-group differences in hypertension, diabetes, prior IV thrombolysis, and onset-to-groin puncture time (calculated with a robust Poisson regression model).